Shifting imaging targets in multiple sclerosis: from inflammation to neurodegeneration (Q34303664)

1 August 2017

Shifting imaging targets in multiple sclerosis: from inflammation to neurodegeneration (English)

1 reference

1 August 2017

0 references

0 references

1 reference

5

Frederik Barkhof

1 reference

1 August 2017

4

Jeroen J G Geurts

1 reference

1 August 2017

René M Vigeveno

1

1 reference

1 August 2017

Oliver T Wiebenga

series ordinal

2

1 reference

1 August 2017

Mike P Wattjes

series ordinal

3

1 reference

1 August 2017

1 July 2012

1 reference

Journal of Magnetic Resonance Imaging

1 August 2017

1 reference

1 August 2017

36

1 reference

1 August 2017

1

1 reference

1 August 2017

1-19

1 reference

Temporal trends in the incidence of multiple sclerosis: a systematic review

1 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Risk alleles for multiple sclerosis identified by a genomewide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Evidence for polygenic susceptibility to multiple sclerosis--the shape of things to come

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Environmental risk factors for multiple sclerosis. Part I: The role of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Vitamin D and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

The natural history of primary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Benign course in multiple sclerosis: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Multiple sclerosis--the plaque and its pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Gray matter pathology in (chronic) MS: modern views on an early observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Grey matter pathology in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

The clinico-radiological paradox in multiple sclerosis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Structural brain abnormalities in multiple sclerosis patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

MR imaging in multiple sclerosis: review and recommendations for current practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Spinal-cord MRI in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Magnetic resonance imaging at 3.0 tesla detects more lesions in acute optic neuritis than at 1.5 tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Higher sensitivity in the detection of inflammatory brain lesions in patients with clinically isolated syndromes suggestive of multiple sclerosis using high field MRI: an intraindividual comparison of 1.5 T with 3.0 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Seven-Tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation".

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Optimizing the association between disability and biological markers in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Predictive value of MRI findings in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/Canadian double-blind, placebo-controlled, MRI-monitored trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

A controlled trial of natalizumab for relapsing multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFNbeta-1b

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Defining interferon beta response status in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Predicting responders to therapies for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Natalizumab drug holiday in multiple sclerosis: poorly tolerated

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Quantitative cerebral anatomy of the aging human brain: a cross-sectional study using magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

The measurement and clinical relevance of brain atrophy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Conventional MRI in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes".

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Quantitative magnetization transfer imaging of pre-lesional white-matter changes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Evolution of focal and diffuse magnetisation transfer abnormalities in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging--evidence of Wallerian degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Relationships of brain white matter microstructure with clinical and MR measures in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Clinically isolated syndrome suggestive of multiple sclerosis: voxelwise regional investigation of white and gray matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Regional DTI differences in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Proton magnetic resonance spectroscopy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Axonal metabolic recovery and potential neuroprotective effect of glatiramer acetate in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Spinal cord gray matter demyelination in multiple sclerosis-a novel pattern of residual plaque morphology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

High-resolution phased-array MRI of the human brain at 7 tesla: initial experience in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Human gray matter: feasibility of single-slab 3D double inversion-recovery high-spatial-resolution MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Improved Identification of Intracortical Lesions in Multiple Sclerosis with Phase-Sensitive Inversion Recovery in Combination with Fast Double Inversion Recovery MR Imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Morphology and evolution of cortical lesions in multiple sclerosis. A longitudinal MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Diffusion-tensor MR imaging of cortical lesions in multiple sclerosis: initial findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Thalamic involvement and its impact on clinical disability in patients with multiple sclerosis: a diffusion tensor imaging study at 3T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Magnetization transfer and diffusion tensor MR imaging of basal ganglia from patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Voxel-based analysis of grey matter magnetization transfer ratio maps in early relapsing remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Magnetization transfer ratio in gray matter: a potential surrogate marker for progression in early primary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

(1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

(1)H-MRSI evidence for cortical gray matter pathology that is independent of cerebral white matter lesion load in patients with secondary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

MRI assessment of iron deposition in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Iron in chronic brain disorders: imaging and neurotherapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Gray matter atrophy in multiple sclerosis: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Cortical atrophy is relevant in multiple sclerosis at clinical onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Widespread cortical thinning characterizes patients with MS with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Relationship of cortical atrophy to fatigue in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Regional grey matter atrophy in clinically isolated syndromes at presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Deep gray matter atrophy in multiple sclerosis: a tensor based morphometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Regional hippocampal atrophy in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Hippocampal atrophy in relapsing-remitting and primary progressive MS: a comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Thalamic damage and long-term progression of disability in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Investigations into resting-state connectivity using independent component analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Consistent resting-state networks across healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Functional connectivity in single and multislice echoplanar imaging using resting-state fluctuations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Neurophysiological architecture of functional magnetic resonance images of human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Functionally linked resting-state networks reflect the underlying structural connectivity architecture of the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Spontaneous neuronal activity distinguishes human dorsal and ventral attention systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Intrinsic functional relations between human cerebral cortex and thalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

The human brain is intrinsically organized into dynamic, anticorrelated functional networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Functional connectivity in the resting brain: a network analysis of the default mode hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Recovery from optic neuritis: an ROI-based analysis of LGN and visual cortical areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Neuroplasticity predicts outcome of optic neuritis independent of tissue damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Primary progressive multiple sclerosis: tactile-associated functional MR activity in the cervical spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Spinal cord neuronal pathology in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Magnetic resonance study of the influence of tissue damage and cortical reorganization on PASAT performance at the earliest stage of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

A paced visual serial addition test for fMRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Cognitive function and fMRI in patients with multiple sclerosis: evidence for compensatory cortical activation during an attention task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: functional magnetic resonance imaging evidence for cognitive reserve.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Default-mode network dysfunction and cognitive impairment in progressive MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Distributed changes in default-mode resting-state connectivity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

fMRI study of episodic memory in relapsing-remitting MS: correlation with T2 lesion volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

An fMRI study of planning-related brain activity in patients with moderately advanced multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Examination of processing speed deficits in multiple sclerosis using functional magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Activity of attention related structures in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Analysis of impairment related functional architecture in MS patients during performance of different attention tasks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Altered functional connectivity related to white matter changes inside the working memory network at the very early stage of MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Evidence for widespread movement-associated functional MRI changes in patients with PPMS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Cortical functional reorganization and its relationship with brain structural damage in patients with benign multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Preserved brain adaptive properties in patients with benign multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Adaptive cortical changes and the functional correlates of visuo-motor integration in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

A functional magnetic resonance imaging study of patients with secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Structural and functional magnetic resonance imaging correlates of motor network dysfunction in primary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Structural connectivity influences brain activation during PVSAT in Multiple Sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Impaired small-world efficiency in structural cortical networks in multiple sclerosis associated with white matter lesion load

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Diffusion tensor tractography reveals disrupted topological efficiency in white matter structural networks in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Graph theoretical analysis of structural and functional connectivity MRI in normal and pathological brain networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Complex brain networks: graph theoretical analysis of structural and functional systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

In vivo MR imaging of hippocampal lesions in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Smoking is a risk factor for multiple sclerosis: a metanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Parent-of-origin effect in multiple sclerosis: observations in half-siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Simple and complex movement-associated functional MRI changes in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Cervical cord functional MRI changes in relapse-onset MS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Altered functional and structural connectivities in patients with MS: A 3-T study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

Structural and functional MRI correlates of Stroop control in benign MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

The natural history of secondary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23578

21 January 2018

Identifiers

DOI

10.1002/JMRI.23578

1 reference

release_5yhormyhqzcxbau2nrufvahife

1 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5yhormyhqzcxbau2nrufvahife

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference